GC Biopharma Supplies 5.94 Million Doses of Flu Vaccine to Thailand 작성일 04-23 133 목록 <div class="article_view" data-translation-body="true" data-tiara-layer="article_body" data-tiara-action-name="본문이미지확대_클릭"> <section dmcf-sid="p0lkwWphEU"> <p contents-hash="9ee387c559ab0283e87e83aec6cde4d99439fbb150a106f485688b06717422bf" dmcf-pid="UpSErYUlOp" dmcf-ptype="general"> [Kim Saemi, Edaily Reporter] GC Biopharma Corp. has secured its largest-ever flu vaccine order in Thailand, the company announced April 23, with plans to supply 5.94 million doses of its ‘GCFLU’ vaccine to Thailand. The bidding volume is estimated to be around 20 billion won.</p> <figure class="figure_frm origin_fig" contents-hash="5a16119ffc094b41c832f0f160cd77c72fb527601836378c4c132b8b8b8535b3" dmcf-pid="uUvDmGuSE0" dmcf-ptype="figure"> <p class="link_figure"><img alt="GC Biopharma Corp. Headquarters (Source=GC Biopharma Corp.)" class="thumb_g_article" data-org-src="https://t1.daumcdn.net/news/202504/23/Edaily/20250423153620262fhvh.jpg" data-org-width="349" dmcf-mid="0M6zbRA8wu" dmcf-mtype="image" height="auto" src="https://img4.daumcdn.net/thumb/R658x0.q70/?fname=https://t1.daumcdn.net/news/202504/23/Edaily/20250423153620262fhvh.jpg" width="658"></p> <figcaption class="txt_caption default_figure"> GC Biopharma Corp. Headquarters (Source=GC Biopharma Corp.) </figcaption> </figure> <div contents-hash="1032172878fabae6e2e0f863245b0c06e2fbe88db8acaeb8b1d3e750ce97b458" dmcf-pid="7uTwsH7vw3" dmcf-ptype="general"> The order includes contracts from Thailand’s Government Pharmaceutical Organization (GPO), the Department of Disease Control (DDC), and the private market. With this deal, GCFLU is expected to surpass a cumulative total of 15 million doses supplied to Thailand since entering the market in 2014. </div> <p contents-hash="ba9f43bab57baf45719f21ae3ac59e14f42abd019490f6a5bffdbfb86d58b65e" dmcf-pid="z7yrOXzTIF" dmcf-ptype="general">Thailand follows flu vaccination guidelines from the World Health Organization (WHO) for both regions. The country has year-round demand for flu vaccines.</p> <p contents-hash="43d70dc1bdadd3330bf599e170a3c6c1af56ef8e55609f1fd50ca13a3c9bc97b" dmcf-pid="qzWmIZqyIt" dmcf-ptype="general">GC Biopharma won tenders from both the GPO’s Northern and Southern Hemisphere bids, as well as the Thai government’s national procurement involving the DDC. The volume of flu vaccines supplied to Thailand’s private sector also grew 112% compared to the previous year.</p> <p contents-hash="4ff1349b95226ebf9492433ae563722a1806682d8aa1b178256cc6b59c3ec6ed" dmcf-pid="BqYsC5BWm1" dmcf-ptype="general">GCFLU is currently exported to 63 countries, with volumes and global reach continuing to expand annually. The vaccine has established itself as a key player in the global flu vaccine market. GC Biopharma is also the largest supplier of flu vaccines to WHO-affiliated international organizations, with cumulative production exceeding 300 million doses.</p> <p contents-hash="6bcf4a32a8ec4cfe71eb490a795690cd963f0870372af0d9b6f3f59763bca6c8" dmcf-pid="bBGOh1bYs5" dmcf-ptype="general">Woojin Lee, head of global business at GC Biopharma, credited strong regulatory support from South Korea’s Ministry of Food and Drug Safety for accelerating export approvals and batch release timelines. “With our product quality proven through years of international procurement contracts, we are committed to promoting the excellence of GCFLU globally,” he said.</p> <p contents-hash="dca037365190769cd041a5c9385f62960069d6a30ee08112deb5fe97ce5cf9bc" dmcf-pid="KbHIltKGDZ" dmcf-ptype="general">김새미 (bird@edaily.co.kr) </p> </section> </div> <p class="" data-translation="true">Copyright © 이데일리. 무단전재 및 재배포 금지.</p> 관련자료 이전 네이버 “외산 기술 도입해 韓상표 붙인다고 소버린 AI 되진 않아” 04-23 다음 논란의 ‘이기흥식 셀프 연임 승인’ 다시는 못 본다…유승민이 쏜 개혁 바람 본격화 04-23 댓글 0 등록된 댓글이 없습니다. 로그인한 회원만 댓글 등록이 가능합니다.
